Posted on 4/9/18
RXi Pharmaceuticals Announces $4.9 Million Registered Direct Offering
RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company developing immuno-oncology therapeutics based on its proprietary self-delivering RNAi (sd-rxRNA®) therapeutic platform, announced today that it has entered . . .
Posted on 4/9/18
InVivo Therapeutics Provides Business Update
CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (Nasdaq:NVIV) today provided a general business update. The company is announcing a 1-for-25 reverse stock split of its common stock . . .
Posted on 4/9/18
Ironwood Pharmaceuticals Announces Director Nomination from Sarissa Capital
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD), a commercial biotech company, today announced that it has received notice from Sarissa Capital Management LP that it intends . . .
Posted on 4/9/18
Charles River Laboratories and PathoQuest Expand Strategic Biologics Partnership
WILMINGTON, Mass. & PARIS--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) and PathoQuest today announced an expansion of their strategic partnership agreement to provide next-generation sequencing . . .
Posted on 4/9/18
Be The Match BioTherapies Strengthens Partnership with Magenta Therapeutics
MINNEAPOLIS & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Be The Match BioTherapies®, an organization offering solutions for companies developing and delivering cellular therapies, today announced that it has made its . . .
Posted on 4/9/18
Verastem Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BOSTON--(BUSINESS WIRE)--Verastem, Inc. (Nasdaq:VSTM), focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients, today announced the grant of . . .
Posted on 4/9/18
Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
WALTHAM, Mass.--(BUSINESS WIRE)--Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the development and commercialization of product candidates using its proprietary mucus-penetrating particle (MPP) technology, today . . .
Posted on 4/9/18
Constellation Pharmaceuticals Announces $100 Million Financing
Constellation Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing tumor-targeted and immuno-oncology therapies based on its pioneering research
Posted on 4/8/18
Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development and commercialization of innovative and effective drug candidates for the treatment of human cancers, today . . .
Posted on 4/8/18
Synlogic Announces Registered Direct Offering of Common Stock
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage company applying synthetic biology to probiotics to develop novel living medicines, today announced that it has agreed to . . .
Posted on 4/8/18
Boston Therapeutics Awarded Key European Patent
LAWRENCE, Mass., April 06, 2018 (GLOBE NEWSWIRE) -- Boston Therapeutics (OTCQB:BTHE) is pleased to announce that it has won a patent position argued with the European Patent . . .
Posted on 4/8/18
Flexion Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
BURLINGTON, Mass., April 06, 2018 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced a grant of inducement stock options to four new employees for an . . .
Posted on 4/5/18
ReForm Biologics and KBI Biopharma Announce Strategic Partnership
CAMBRIDGE, Mass. & DURHAM, N.C.--(BUSINESS WIRE)--ReForm Biologics and KBI Biopharma, Inc., (KBI) today announced a strategic partnership to make improved biopharmaceutical formulations. Through this collaboration, KBI . . .
Posted on 4/4/18
Q-State Biosciences and Vertex Pharmaceuticals Enter into Multi-Year Drug Discovery Collaboration
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Q-State Biosciences, Inc. today announced that the company has entered into a strategic collaboration with Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) to discover drugs using . . .
Posted on 4/4/18
Sage Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sage Therapeutics (NASDAQ: SAGE), a clinical-stage biopharmaceutical company developing novel medicines to treat life-altering central nervous system (CNS) disorders, today announced that, on April . . .
Posted on 4/3/18
Homology Medicines Closes IPO
Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, announced today the closing of its initial public offering of 10,350,000 shares of common stock at a . . .
Posted on 4/3/18
TriCare Earns Top Customer Experience Ratings for Health Plans
TriCare delivers the best customer experience in the health plan industry, according to the 2018 Temkin Experience Ratings, an annual customer experience benchmark of companies based . . .
Posted on 4/3/18
Unum Therapeutics Closes IPO
CAMBRIDGE, Mass., April 03, 2018 (GLOBE NEWSWIRE) -- Unum Therapeutics Inc., a clinical-stage biopharmaceutical company focused on the development of novel immunotherapy products designed to harness . . .
Posted on 4/3/18
Albireo Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BOSTON, April 03, 2018 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq:ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced the . . .
Posted on 4/3/18
Boston Scientific Acquires Securus Medical For $50M
Boston Scientific Corporation (NYSE: BSX) today announced the acquisition of Securus Medical Group, Inc., a privately-held company that has developed a thermal monitoring
Posted on 4/3/18
RA Capital Management Opposes BioCryst Pharmaceuticals' Proposed Merger with Idera Pharmaceuticals
RA Capital Management, LLC announced that it delivered a letter to the Board of Directors of BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) conveying its opposition to BioCryst's . . .
Posted on 4/3/18
Karyopharm Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
NEWTON, Mass., April 02, 2018 (GLOBE NEWSWIRE) -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a clinical-stage pharmaceutical company, today announced that the Compensation Committee of Karyopharm’s Board of . . .
Posted on 4/3/18
Rhythm Pharmaceuticals Announces Licensing Agreement with Takeda
BOSTON, April 02, 2018 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM), a biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare genetic . . .
Posted on 4/2/18
Biostage Reports 2017 Financial Results
Biostage, Inc. (OTCQB: BSTG), a biotechnology company developing bioengineered organ implants to treat life-threatening conditions of the esophagus, bronchus and trachea, today announced financial results for . . .
Posted on 4/2/18
Better Buy: Biogen Inc. vs. Amgen Inc.
As far as biotechs go, Biogen (NASDAQ:BIIB) and Amgen (NASDAQ:AMGN) are ancient. Biogen was founded in 1978, while Amgen started operations a couple of years later. . . .

